2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Intraabdominal Infections: new trials by email Literature Review of Intraabdominal Infections trials Research Report on Intraabdominal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury Reltecimod 0.5 mg/kg, Placebo - Acute Kidney Injury, Peritonitis | Phase 3 | Terminated | Atox Bio Ltd | 58 | 2018-05-24 | 2021-10-12 |
| A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections Doripenem, Meropenem placebo, Meropenem - Abscess, Intra-Abdominal, Abdominal Abscess | Phase 3 | Terminated | Janssen Research & Development, LLC | 41 | 2010-12-01 | 2014-07-15 |
Peritonitis (2) · Abdomen, Acute (1) · Abdominal Abscess (1) · Abdominal Pain (1) · Acute Kidney Injury (1) · Appendicitis (1) · Ileus (1) · Infections (1) · Intestinal Perforation (1) · Rupture (1)
Digestive System Diseases (2) · Peritoneal Diseases (2) · Abscess (1) · Cecal Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Infections (1) · Intestinal Diseases (1) · Intestinal Obstruction (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Neurologic Manifestations (1)
AB103 (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Doripenem (1) · Meropenem (1) · Saline Solution (1) · Sodium Chloride (1)
Atox Bio Ltd (1) · Janssen Research & Development, LLC (1)
United States (2) · Argentina (1) · Brazil (1) · Chile (1) · Colombia (1) · France (1) · Latvia (1) · Lithuania (1) · Panama (1)
Azra Bihorac, MD (1)
2009 (1)